Level Four Advisory Services LLC Increases Stock Holdings in Axon Enterprise, Inc. (NASDAQ:AXON)

Level Four Advisory Services LLC boosted its stake in Axon Enterprise, Inc. (NASDAQ:AXON) by 23.3% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 968 shares of the biotechnology company’s stock after acquiring an additional 183 shares during the quarter. Level Four Advisory Services LLC’s holdings in Axon Enterprise were worth $575,000 at the end of the most recent reporting period.

Several other large investors also recently bought and sold shares of the company. Public Sector Pension Investment Board boosted its stake in shares of Axon Enterprise by 19.2% in the third quarter. Public Sector Pension Investment Board now owns 3,104 shares of the biotechnology company’s stock valued at $1,240,000 after purchasing an additional 500 shares during the period. Friedenthal Financial boosted its position in Axon Enterprise by 961.7% in the 4th quarter. Friedenthal Financial now owns 1,359 shares of the biotechnology company’s stock valued at $808,000 after buying an additional 1,231 shares during the last quarter. Principal Financial Group Inc. grew its stake in shares of Axon Enterprise by 33.1% during the third quarter. Principal Financial Group Inc. now owns 136,302 shares of the biotechnology company’s stock valued at $54,466,000 after acquiring an additional 33,869 shares in the last quarter. XTX Topco Ltd increased its position in shares of Axon Enterprise by 20.6% during the third quarter. XTX Topco Ltd now owns 5,650 shares of the biotechnology company’s stock worth $2,258,000 after acquiring an additional 964 shares during the last quarter. Finally, Artemis Investment Management LLP boosted its holdings in Axon Enterprise by 21.4% in the fourth quarter. Artemis Investment Management LLP now owns 95,113 shares of the biotechnology company’s stock valued at $56,528,000 after purchasing an additional 16,792 shares during the last quarter. Institutional investors and hedge funds own 79.08% of the company’s stock.

Insider Activity

In other news, Director Caitlin Elizabeth Kalinowski sold 450 shares of Axon Enterprise stock in a transaction that occurred on Thursday, January 2nd. The stock was sold at an average price of $604.07, for a total transaction of $271,831.50. Following the sale, the director now owns 6,929 shares of the company’s stock, valued at approximately $4,185,601.03. The trade was a 6.10 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director Jeri Williams sold 307 shares of the stock in a transaction that occurred on Monday, March 17th. The stock was sold at an average price of $552.72, for a total value of $169,685.04. Following the completion of the transaction, the director now directly owns 1,627 shares of the company’s stock, valued at $899,275.44. This trade represents a 15.87 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 6.10% of the company’s stock.

Axon Enterprise Trading Down 2.9 %

NASDAQ:AXON opened at $534.95 on Monday. Axon Enterprise, Inc. has a 12-month low of $273.52 and a 12-month high of $715.99. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.96 and a quick ratio of 2.63. The business has a 50 day simple moving average of $589.62 and a 200 day simple moving average of $550.61. The firm has a market capitalization of $40.99 billion, a P/E ratio of 138.23, a P/E/G ratio of 5.17 and a beta of 1.12.

Wall Street Analysts Forecast Growth

Several equities research analysts have issued reports on AXON shares. Robert W. Baird lifted their price objective on Axon Enterprise from $600.00 to $800.00 and gave the stock an “outperform” rating in a report on Friday, December 6th. Craig Hallum cut shares of Axon Enterprise from a “buy” rating to a “cautious” rating in a report on Monday, March 10th. The Goldman Sachs Group raised their price objective on shares of Axon Enterprise from $500.00 to $700.00 and gave the stock a “buy” rating in a report on Monday, January 27th. Barclays restated a “hold” rating on shares of Axon Enterprise in a research note on Monday, March 10th. Finally, Needham & Company LLC reiterated a “buy” rating and issued a $600.00 price target on shares of Axon Enterprise in a research note on Wednesday, February 26th. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating and eleven have given a buy rating to the company. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $604.67.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.